Innate Pharma S.A. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was EUR 70.451 million compared to EUR 85.814 million a year ago. Net loss was EUR 63.984 million compared to EUR 20.759 million a year ago. Basic loss per share from continuing operations was EUR 0.81 compared to EUR 0.31 a year ago.